相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Mitigation Measures for Pandemic Influenza in Italy: An Individual Based Model Considering Different Scenarios
Marta Luisa Ciofi degli Atti et al.
PLOS ONE (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
Benoit Baras et al.
PLOS ONE (2008)
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Hans C. Rumke et al.
VACCINE (2008)
Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years
Ruprecht Schmidt-Ott et al.
VACCINE (2007)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada
D. M. Skowronski et al.
VACCINE (2007)
Reference viruses for seasonal and pandemic influenza vaccine preparation
John M. Wood et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
Strategies for mitigating an influenza pandemic
Neil M. Ferguson et al.
NATURE (2006)
Fluarix™, inactivated split-virus influenza vaccine
GW Rose et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Rapid Licensure of a New, Inactivated Influenza Vaccine in the United States
John J. Treanor et al.
HUMAN VACCINES (2005)
Containing pandemic influenza at the source
IM Longini et al.
SCIENCE (2005)
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice
AO Hovden et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Improved design of the annual influenza vaccine using epitope analysis
VA Ferro
EXPERT REVIEW OF VACCINES (2005)
Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use
N Hehme et al.
VIRUS RESEARCH (2004)
Prevention of influenza in the general population
JM Langley et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
KL Nichol
VACCINE (2003)
Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines
N Hehme et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2002)
Ten years of experience with the trivalent split-influenza vaccine, Fluarix (TM)
NW Hehme et al.
CLINICAL DRUG INVESTIGATION (2002)
分享论文
